At Fuse Vectors, our mission is to revolutionize AAV gene therapy development. Traditional cell-based technologies have hindered progress, posing challenges in safety, efficacy, development time, and cost. Our Cell-Free AAV technology surpasses these methods, producing safer, more effective, and cost-efficient AAV viral vectors in a fraction of the time.
Location: Denmark, Capital Region of Denmark, Copenhagen
Total raised: $5.2M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.03.2025 | Pre-Seed | $5.2M | - |
Mentions in press and media 6
| Date | Title | Description |
| 07.03.2025 | Fuse Vectors: $5.2 Million (Pre-Seed) Raised For Advancing Cell-Free Gene Therapy Technology | Fuse Vectors recently announced $5.2 million in pre-seed financing led by HCVC to transform gene therapy development with its cell-free viral vector technology. This funding will accelerate the development of Fuse’s technology platform and ... |
| 28.02.2025 | Fuse Vectors: Pioneering a New Era in Gene Therapy | In the bustling world of biotechnology, innovation is the lifeblood that fuels progress. Fuse Vectors, a Copenhagen-based startup, is at the forefront of this revolution. With a recent pre-seed funding round of $5.2 million, the company is ... |
| 25.02.2025 | Fuse Vectors Raises $5.2M in Pre-Seed Funding | Fuse Vectors founders L to R Jordan Turnbull, Henrik Stage and Benjamin Blaha Fuse Vectors, a Copenhagen, Denmark-based gene therapy company, raised $5.2M in Pre-Seed Funding. The round was led by HCVC. The company intends to use the funds ... |
| 25.02.2025 | Fuse Vectors secures over €4.9 million for gene therapy with its cell-free viral vector technology | Copenhagen-based BioTech startup Fuse Vectors announces €4.9 million in pre-Seed financing to innovate gene therapy development with its cell-free viral vector technology. The funding includes investment from HCVC and support from BioInnova... |
| 25.02.2025 | Biotech Fuse Vectors secures $5.2M to advance cell-free gene therapy tech | Fuse Vectors has raised $5.2M in pre-seed financing led by HCVC for its cell-free viral vector technology. The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. Fuse Vectors is a bio... |
| - | Fuse Vectors | “Home | Fuse Vectors” |